{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:36:53Z","timestamp":1793227013765,"version":"4.5.0"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"7-8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Novel benzofurane-pyrazolone hybrids have been synthesized for evaluating their anti-inflammatory and cytotoxic properties. 4-(2-chloroacetyl)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one were reacted with \u03b1-hydroxy aldehyde or \u03b1-hydroxy ketone derivatives to obtain nine novel pyrazolone derivatives. Structures were successfully elucidated by <jats:sup>1<\/jats:sup>H NMR, <jats:sup>13<\/jats:sup>C NMR, IR and HRMS. Enzyme inhibitory activity was measured on cyclooxygenases (COXs) as considered to address anti-inflammatory activity. Compound <jats:bold>2<\/jats:bold> showed the highest activity on both COX-1 and COX-2 subtypes with 12.0\u00a0\u03bcM and 8.0\u00a0\u03bcM IC<jats:sub>50<\/jats:sub>, respectively. This activity was found close to indomethacin COX-2 inhibition measured as 7.4\u00a0\u03bcM IC<jats:sub>50<\/jats:sub>. Rest of the compounds (<jats:bold>1<\/jats:bold>, <jats:bold>3<\/jats:bold>\u2013<jats:bold>9<\/jats:bold>) showed 10.4\u201328.1\u00a0\u03bcM IC<jats:sub>50<\/jats:sub> on COX-2 and 17.0\u201335.6\u00a0\u03bcM IC<jats:sub>50<\/jats:sub> on COX-1 (Compound <jats:bold>1<\/jats:bold> has no activity on COX-1). Tested compounds (<jats:bold>1\u20139<\/jats:bold>) showed activity on NO production. Only compound was the <jats:bold>4<\/jats:bold>, which showed a low inhibition on IL-6 levels. Cell viability was up to 60% at 100\u00a0\u03bcM for all compounds (<jats:bold>1<\/jats:bold>\u2013<jats:bold>9<\/jats:bold>) on RAW 264.7 and NIH3T3 cell lines, thus compounds were reported to be noncytotoxic.<\/jats:p>","DOI":"10.1515\/znc-2021-0217","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T20:26:30Z","timestamp":1639427190000},"page":"279-285","source":"Crossref","is-referenced-by-count":5,"title":["Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluation"],"prefix":"10.1515","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-676X","authenticated-orcid":false,"given":"Zafer","family":"Sahin","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry , School of Pharmacy, Istanbul Medipol University , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-3281","authenticated-orcid":false,"given":"Ya\u011fmur","family":"\u00d6zhan","sequence":"additional","affiliation":[{"name":"Department of Toxicology , Faculty of Pharmacy, Yeditepe University , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-3143","authenticated-orcid":false,"given":"Hande","family":"Sipahi","sequence":"additional","affiliation":[{"name":"Department of Toxicology , Faculty of Pharmacy, Yeditepe University , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1896-2729","authenticated-orcid":false,"given":"Sevde Nur","family":"Biltekin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology , School of Pharmacy, Istanbul Medipol University , Istanbul , Turkey"},{"name":"Institute of Science, Istanbul University , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0957-6044","authenticated-orcid":false,"given":"Leyla","family":"Yurtta\u015f","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry , Faculty of Pharmacy, Anadolu University , Eskisehir , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6047-2796","authenticated-orcid":false,"given":"Barkin","family":"Berk","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry , School of Pharmacy, Istanbul Medipol University , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-1299","authenticated-orcid":false,"given":"\u015eeref","family":"Demirayak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry , School of Pharmacy, Istanbul Medipol University , Istanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"2023040103074333501_j_znc-2021-0217_ref_001","unstructured":"Ian Todd, GS, Fairclough, L. Immunology: lecture notes. New York: John Wiley & Sons; 2015."},{"key":"2023040103074333501_j_znc-2021-0217_ref_002","doi-asserted-by":"crossref","unstructured":"Netea, MG, Balkwill, F, Chonchol, M, Cominelli, F, Donath, MY, Giamarellos-Bourboulis, EJ, et al.. A guiding map for inflammation. Nat Immunol 2017;18:826\u201331. https:\/\/doi.org\/10.1038\/ni.3790.","DOI":"10.1038\/ni.3790"},{"key":"2023040103074333501_j_znc-2021-0217_ref_003","doi-asserted-by":"crossref","unstructured":"Kurumbail, RG, Kiefer, JR, Marnett, LJ. Cyclooxygenase enzymes: catalysis and inhibition. Curr Opin Struct Biol 2001;11:752\u201360. https:\/\/doi.org\/10.1016\/s0959-440x(01)00277-9.","DOI":"10.1016\/S0959-440X(01)00277-9"},{"key":"2023040103074333501_j_znc-2021-0217_ref_004","doi-asserted-by":"crossref","unstructured":"Shrivastava, SK, Srivastava, P, Bandresh, R, Tripathi, PN, Tripathi, A. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Bioorg Med Chem 2017;25:4424\u201332. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.027.","DOI":"10.1016\/j.bmc.2017.06.027"},{"key":"2023040103074333501_j_znc-2021-0217_ref_005","doi-asserted-by":"crossref","unstructured":"Norregaard, R, Kwon, TH, Frokiaer, J. Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney. Kidney Res Clin Pract 2015;34:194\u2013200. https:\/\/doi.org\/10.1016\/j.krcp.2015.10.004.","DOI":"10.1016\/j.krcp.2015.10.004"},{"key":"2023040103074333501_j_znc-2021-0217_ref_006","doi-asserted-by":"crossref","unstructured":"Taciak, B, Bialasek, M, Braniewska, A, Sas, Z, Sawicka, P, Kiraga, L, et al.. Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages. PLoS One 2018;13:e0198943. https:\/\/doi.org\/10.1371\/journal.pone.0198943.","DOI":"10.1371\/journal.pone.0198943"},{"key":"2023040103074333501_j_znc-2021-0217_ref_007","doi-asserted-by":"crossref","unstructured":"Karadag, AE, Demirci, B, Caskurlu, A, Demirci, F, Okur, ME, Orak, D, et al.. In vitro antibacterial, antioxidant, anti-inflammatory and analgesic evaluation of Rosmarinus officinalis L. flower extract fractions. South Afr J Bot 2019;125:214\u201320.","DOI":"10.1016\/j.sajb.2019.07.039"},{"key":"2023040103074333501_j_znc-2021-0217_ref_008","doi-asserted-by":"crossref","unstructured":"Gao, Y, Jiang, W, Dong, C, Li, C, Fu, X, Min, L, et al.. Anti-inflammatory effects of sophocarpine in LPS-induced RAW 264.7 cells via NF-kappaB and MAPKs signaling pathways. Toxicol Vitro 2012;26:1\u20136. https:\/\/doi.org\/10.1016\/j.tiv.2011.09.019.","DOI":"10.1016\/j.tiv.2011.09.019"},{"key":"2023040103074333501_j_znc-2021-0217_ref_009","doi-asserted-by":"crossref","unstructured":"Lee, JY, Park, W. Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid. Molecules 2011;16:7132\u201342. https:\/\/doi.org\/10.3390\/molecules16087132.","DOI":"10.3390\/molecules16087132"},{"key":"2023040103074333501_j_znc-2021-0217_ref_010","doi-asserted-by":"crossref","unstructured":"Brogden, RN. Pyrazolone derivatives. Drugs 1986;32:60\u201370. https:\/\/doi.org\/10.2165\/00003495-198600324-00006.","DOI":"10.2165\/00003495-198600324-00006"},{"key":"2023040103074333501_j_znc-2021-0217_ref_011","doi-asserted-by":"crossref","unstructured":"Biava, M. Introduction to COX inhibitors. Future Med Chem 2018;10:1737\u201340. https:\/\/doi.org\/10.4155\/fmc-2018-0159.","DOI":"10.4155\/fmc-2018-0159"},{"key":"2023040103074333501_j_znc-2021-0217_ref_012","doi-asserted-by":"crossref","unstructured":"El Sayed, MT, El-Sharief, M, Zarie, ES, Morsy, NM, Elsheakh, AR, Voronkov, A, et al.. Design, synthesis, anti-inflammatory activity and molecular docking of potential novel antipyrine and pyrazolone analogs as cyclooxygenase enzyme (COX) inhibitors. Bioorg Med Chem Lett 2018;28:952\u20137. https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.043.","DOI":"10.1016\/j.bmcl.2018.01.043"},{"key":"2023040103074333501_j_znc-2021-0217_ref_013","doi-asserted-by":"crossref","unstructured":"Farag, AA, El Shehry, MF, Abbas, SY, Abd-Alrahman, SN, Atrees, AA, Al-basheer, HZ, et al.. Synthesis of pyrazoles containing benzofuran and trifluoromethyl moieties as possible anti-inflammatory and analgesic agents. Z Naturforsch B Chem Sci 2015;70:519\u201326. https:\/\/doi.org\/10.1515\/znb-2015-0009.","DOI":"10.1515\/znb-2015-0009"},{"key":"2023040103074333501_j_znc-2021-0217_ref_014","doi-asserted-by":"crossref","unstructured":"Ragab, FA, Eid, NM, Hassan, GS, Nissan, YM. Synthesis and anti-inflammatory activity of some benzofuran and benzopyran-4-one derivatives. Chem Pharm Bull 2012;60:110\u201320. https:\/\/doi.org\/10.1248\/cpb.60.110.","DOI":"10.1248\/cpb.60.110"},{"key":"2023040103074333501_j_znc-2021-0217_ref_015","doi-asserted-by":"crossref","unstructured":"Hu, ZF, Chen, LL, Qi, J, Wang, YH, Zhang, H, Yu, BY. Two new benzofuran derivatives with anti-inflammatory activity from Liriope spicata var. prolifera. Fitoterapia 2011;82:190\u20132. https:\/\/doi.org\/10.1016\/j.fitote.2010.09.002.","DOI":"10.1016\/j.fitote.2010.09.002"},{"key":"2023040103074333501_j_znc-2021-0217_ref_016","doi-asserted-by":"crossref","unstructured":"FitzGerald, GA, Patrono, C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433\u201342. https:\/\/doi.org\/10.1056\/nejm200108093450607.","DOI":"10.1056\/NEJM200108093450607"},{"key":"2023040103074333501_j_znc-2021-0217_ref_017","unstructured":"Riendeau, D, Percival, MD, Brideau, C, Charleson, S, Dube, D, Ethier, D, et al.. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Therapeut 2001;296:558\u201366."},{"key":"2023040103074333501_j_znc-2021-0217_ref_018","doi-asserted-by":"crossref","unstructured":"Okur, ME, Karadag, AE, Ustundag Okur, N, Ozhan, Y, Sipahi, H, Ayla, S, et al.. In vivo wound healing and in\u00a0vitro anti-inflammatory activity evaluation of Phlomis russeliana extract gel formulations. Molecules 2020;25:2695. https:\/\/doi.org\/10.3390\/molecules25112695.","DOI":"10.3390\/molecules25112695"},{"key":"2023040103074333501_j_znc-2021-0217_ref_019","doi-asserted-by":"crossref","unstructured":"Abe, K, Itoyama, Y, Sobue, G, Tsuji, S, Aoki, M, Doyu, M, et al.. Edaravone, Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degeneration 2014;15:610\u20137. https:\/\/doi.org\/10.3109\/21678421.2014.959024.","DOI":"10.3109\/21678421.2014.959024"},{"key":"2023040103074333501_j_znc-2021-0217_ref_020","doi-asserted-by":"crossref","unstructured":"Kaur, A, Wakode, S, Pathak, DP, Sharma, V, Shakya, AK. Synthesis, cyclooxygenase-2 inhibition, anti-inflammatory evaluation and docking study of substituted-N-(3,4,5-trimethoxyphenyl)-benzo[d]oxazole derivatives. Med Chem 2018;14:660\u201373. https:\/\/doi.org\/10.2174\/1573406414666180322091832.","DOI":"10.2174\/1573406414666180322091832"},{"key":"2023040103074333501_j_znc-2021-0217_ref_021","doi-asserted-by":"crossref","unstructured":"Sahin, Z, Biltekin, SN, Yurttas, L, Berk, B, Ozhan, Y, Sipahi, H, et al.. Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: adenosine receptor binding and potent PDE4 inhibition. Eur J Med Chem 2021;212:113125. https:\/\/doi.org\/10.1016\/j.ejmech.2020.113125.","DOI":"10.1016\/j.ejmech.2020.113125"},{"key":"2023040103074333501_j_znc-2021-0217_ref_022","doi-asserted-by":"crossref","unstructured":"Okur, ME, Karadag, AE, Ozhan, Y, Sipahi, H, Ayla, S, Daylan, B, et al.. Anti-inflammatory, analgesic and in vivo-in vitro wound healing potential of the Phlomis rigida Labill. extract. J Ethnopharmacol 2021;266:113408. https:\/\/doi.org\/10.1016\/j.jep.2020.113408.","DOI":"10.1016\/j.jep.2020.113408"},{"key":"2023040103074333501_j_znc-2021-0217_ref_023","doi-asserted-by":"crossref","unstructured":"Erdo\u011fan, M, Konya, R, \u00d6zhan, Y, Sipahi, H, \u00c7inbilgel, \u0130, Masullo, M, et al.. Secondary metabolites from Scutellaria brevibracteata subsp. subvelutina and their in\u00a0vitro anti-inflammatory activities. South Afr J Bot 2021;139:12\u20138.","DOI":"10.1016\/j.sajb.2021.01.028"}],"container-title":["Zeitschrift f\u00fcr Naturforschung C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/znc-2021-0217\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/znc-2021-0217\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T09:22:35Z","timestamp":1680427355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/znc-2021-0217\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":23,"journal-issue":{"issue":"7-8","published-online":{"date-parts":[[2022,3,3]]},"published-print":{"date-parts":[[2022,7,26]]}},"alternative-id":["10.1515\/znc-2021-0217"],"URL":"https:\/\/doi.org\/10.1515\/znc-2021-0217","relation":{},"ISSN":["0939-5075","1865-7125"],"issn-type":[{"value":"0939-5075","type":"print"},{"value":"1865-7125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]}}}